Ventilator-Weaning Pathway Associated With Decreased Ventilator Days in Pediatric Acute Respiratory Distress Syndrome

Sanjiv D Mehta1, Kelly Martin2, Nancy McGowan3

  • 1Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA.

Critical Care Medicine
|November 6, 2020
PubMed

Insights

Protocolized ventilator weaning significantly reduced mechanical ventilation duration in pediatric acute respiratory distress syndrome survivors. This approach improved patient outcomes without increasing reintubation rates, offering a valuable clinical strategy.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Physiology
  • Clinical Trial Methodology

Background:

  • Limited evidence exists on protocolized ventilator weaning for pediatric acute respiratory distress syndrome (ARDS).
  • Understanding the impact of standardized weaning protocols is crucial for optimizing care in pediatric intensive care units (PICUs).

Purpose of the Study:

  • To evaluate if a protocolized ventilator weaning pathway reduces mechanical ventilation duration in pediatric ARDS survivors.
  • To assess the effect of this pathway on Pediatric Intensive Care Unit (PICU) length of stay.

Main Methods:

  • Secondary analysis of a prospective pediatric ARDS cohort (Berlin definition) from 2011-2019.
  • Interrupted time series analysis compared outcomes before and after implementing a ventilator-weaning pathway in May 2016.
  • Included survivors with <= 100 ventilator days; excluded nonsurvivors and those with prolonged ventilation.

Main Results:

  • Pathway implementation was associated with a median decrease of 3.6 ventilator days (p < 0.001).
  • No significant change in reintubation rates was observed post-intervention.
  • Results remained robust after adjusting for confounders and performing sensitivity analyses.

Conclusions:

  • Protocolized ventilator weaning effectively shortens invasive ventilation duration in pediatric ARDS survivors.
  • The intervention demonstrates a significant benefit without compromising patient safety (reintubation rates).
  • The observed effect size is comparable to targets in ARDS clinical trials, supporting its clinical utility.
Abstract

Related Concept Videos

Ventilatory Modes01:14

Ventilatory Modes

Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
877
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
465
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
322
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
813
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
552
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
593